Clene Stock (NASDAQ: CLNN) stock price, news, charts, stock research, profile.
Open | $0.344 |
Close | - |
Volume / Avg. | 64.052K / 909.381K |
Day Range | 0.340 - 0.354 |
52 Wk Range | 0.250 - 1.090 |
Market Cap | $44.926M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.2% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Clene (NASDAQ: CLNN) through any online brokerage.
Other companies in Clene’s space includes: NKGen Biotech (NASDAQ:NKGN), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for Clene (NASDAQ: CLNN) was reported by HC Wainwright & Co. on Wednesday, April 17, 2024. The analyst firm set a price target for 7.00 expecting CLNN to rise to within 12 months (a possible 2014.16% upside). 17 analyst firms have reported ratings in the last year.
The stock price for Clene (NASDAQ: CLNN) is $0.3311 last updated Today at April 29, 2024 at 9:01 AM EDT.
There are no upcoming dividends for Clene.
Clene’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Clene.
Clene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.